|
LU75903A1
(cg-RX-API-DMAC7.html)
|
1976-09-29 |
1978-05-16 |
|
|
|
NL7105591A
(en)
|
1971-04-24 |
1972-10-26 |
|
Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-
|
|
DE2655570A1
(de)
|
1975-12-12 |
1977-06-16 |
Ciba Geigy Ag |
Neue polyhalogensteroide und verfahren zu ihrer herstellung
|
|
US4048310A
(en)
|
1976-02-24 |
1977-09-13 |
E. R. Squibb & Sons, Inc. |
Topical steroid formulation in form of lotion or cream
|
|
US4083974A
(en)
|
1977-03-07 |
1978-04-11 |
The Upjohn Company |
Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
|
|
JPS5850964B2
(ja)
*
|
1978-03-07 |
1983-11-14 |
東興薬品工業株式会社 |
ステロイド含有クリ−ム製剤およびその製造方法
|
|
AU5794680A
(en)
|
1979-05-31 |
1980-12-04 |
E.R. Squibb & Sons, Inc. |
Corticosteroid stick formulations
|
|
US4233295A
(en)
*
|
1979-05-31 |
1980-11-11 |
E. R. Squibb & Sons, Inc. |
Corticosteroid formulations containing sebacate carrier
|
|
US4299828A
(en)
*
|
1979-05-31 |
1981-11-10 |
E. R. Squibb & Sons, Inc. |
Corticosteroid stick formulations
|
|
CH649923A5
(de)
|
1980-10-06 |
1985-06-28 |
Glaxo Group Ltd |
Topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide.
|
|
JPS58225009A
(ja)
|
1982-06-23 |
1983-12-27 |
Shionogi & Co Ltd |
コルチコステロイド外用製剤
|
|
DE3225848A1
(de)
|
1982-07-07 |
1984-01-19 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Kortikoidhaltige zubereitung zur topischen applikation
|
|
US4552872A
(en)
|
1983-06-21 |
1985-11-12 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing corticosteroids
|
|
GB8401965D0
(en)
|
1984-01-25 |
1984-02-29 |
Beecham Group Plc |
Composition
|
|
JPH0764734B2
(ja)
*
|
1986-03-17 |
1995-07-12 |
大正製薬株式会社 |
経皮投与製剤
|
|
CA1303991C
(en)
|
1986-03-31 |
1992-06-23 |
Chung H. Cheng |
Composition and method for delivering a steroid active ingredient
|
|
JPS62238216A
(ja)
*
|
1986-04-03 |
1987-10-19 |
Otsuka Pharmaceut Factory Inc |
ステロイドクリ−ム製剤
|
|
US5019569A
(en)
|
1986-11-03 |
1991-05-28 |
Ortho Pharmaceutical Corporation |
Reversal of glucocorticoid-induced skin atrophy
|
|
JPH0676328B2
(ja)
*
|
1987-04-14 |
1994-09-28 |
株式会社大塚製薬工場 |
ステロイドクリ−ム製剤
|
|
JPH0676327B2
(ja)
|
1987-04-14 |
1994-09-28 |
株式会社大塚製薬工場 |
ステロイド軟膏製剤
|
|
JPH07116026B2
(ja)
|
1987-07-07 |
1995-12-13 |
株式会社資生堂 |
ジクロフェナックナトリウム含有乳化外用剤
|
|
US5422361A
(en)
*
|
1989-12-20 |
1995-06-06 |
Schering Corporation |
Stable cream and lotion bases for lipophilic drug compositions
|
|
EP0471084B1
(en)
|
1990-03-02 |
1996-01-10 |
Shiseido Company Limited |
Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic
|
|
TW218849B
(cg-RX-API-DMAC7.html)
*
|
1991-05-17 |
1994-01-11 |
Bristol Myers Squibb Co |
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
WO1993009583A1
(en)
*
|
1991-10-29 |
1993-05-13 |
Audio Authority Corporation |
Apparatus and method for interconnecting electronic products
|
|
CA2282682C
(en)
|
1997-02-20 |
2008-08-19 |
Allergan Sales, Inc. |
Tazarotene and corticosteroid treatment for psoriasis
|
|
US5972920A
(en)
*
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
|
SE9800729L
(sv)
|
1998-03-06 |
1999-09-07 |
Scotia Lipidteknik Ab |
Ny topikal formulering I
|
|
US5990100A
(en)
*
|
1998-03-24 |
1999-11-23 |
Panda Pharmaceuticals, L.L.C. |
Composition and method for treatment of psoriasis
|
|
GB9823036D0
(en)
*
|
1998-10-22 |
1998-12-16 |
Glaxo Group Ltd |
Fluticasone lotion having improved vasoconstrictor activity
|
|
WO2000040250A1
(fr)
*
|
1999-01-06 |
2000-07-13 |
Taisho Pharmaceutical Co.,Ltd. |
Lotion a base d'amelometasone
|
|
WO2000047211A1
(en)
|
1999-02-12 |
2000-08-17 |
Susan Bershad |
Short contact treatment of psoriasis with topical retinoids
|
|
CA2376850C
(en)
|
1999-06-25 |
2009-11-17 |
Durham Pharmaceuticals Ltd. |
Topical formulations comprising skin penetration agents and the use thereof
|
|
US6656928B1
(en)
*
|
1999-09-02 |
2003-12-02 |
Mccadden Michael E. |
Composition for the topical treatment of rashes, dermatoses and lesions
|
|
US6479058B1
(en)
|
1999-09-02 |
2002-11-12 |
Mccadden Michael E. |
Composition for the topical treatment of poison ivy and other forms of contact dermatitis
|
|
US6387383B1
(en)
|
2000-08-03 |
2002-05-14 |
Dow Pharmaceutical Sciences |
Topical low-viscosity gel composition
|
|
US6579512B2
(en)
*
|
2001-06-15 |
2003-06-17 |
Crutchfield, Iii Charles E. |
Topical steroid spray
|
|
US6709663B2
(en)
|
2001-08-31 |
2004-03-23 |
Healthpoint, Ltd. |
Multivesicular emulsion drug delivery systems
|
|
US6765001B2
(en)
|
2001-12-21 |
2004-07-20 |
Medicis Pharmaceutical Corporation |
Compositions and methods for enhancing corticosteroid delivery
|
|
ES2298438T3
(es)
*
|
2001-12-21 |
2008-05-16 |
Rhodia Inc. |
Composiciones estables combinadas de tensioactivos cationicos y anionicos.
|
|
US7544674B2
(en)
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US20060018937A1
(en)
|
2002-10-25 |
2006-01-26 |
Foamix Ltd. |
Steroid kit and foamable composition and uses thereof
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
JP2004359585A
(ja)
|
2003-06-03 |
2004-12-24 |
Medorekkusu:Kk |
被膜形成型の副腎皮質ステロイド薬含有外用製剤
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US8741333B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for treating dermatitis or psoriasis
|
|
US8449867B2
(en)
*
|
2004-08-31 |
2013-05-28 |
Stiefel Research Australia Pty Ltd |
Microemulsion and sub-micron emulsion process and compositions
|
|
CA2601123A1
(en)
|
2005-03-15 |
2006-09-21 |
Kyowa Hakko Kogyo Co., Ltd. |
External preparation
|
|
MX2007013230A
(es)
|
2005-04-25 |
2008-04-17 |
Dow Pharmaceutical Sciences Y |
Uso de una formulacion en aerosol de clobetasol para tratar psoriasis.
|
|
MX2008007439A
(es)
|
2005-12-09 |
2009-01-22 |
Nycomed Inc |
Formulaciones glucocorticosteroides topicas.
|
|
JP2009519956A
(ja)
|
2005-12-14 |
2009-05-21 |
ザーズ， インコーポレイテッド |
薬物の皮膚送達のための組成物および方法
|
|
SI2494959T1
(sl)
|
2006-07-05 |
2015-04-30 |
Foamix Pharmaceuticals Ltd. |
Penilno sredstvo dikarboksilne kisline in njega farmacevtski sestavki
|
|
WO2008152444A2
(en)
|
2006-11-29 |
2008-12-18 |
Foamix Ltd. |
Foamable waterless compositions with modulating agents
|
|
US20100323998A1
(en)
*
|
2007-08-06 |
2010-12-23 |
Glenmark Pharmaceuticals Ltd. |
Topical composition containing the combination of mupirocin and beclomethasone
|
|
WO2009063493A2
(en)
|
2007-09-10 |
2009-05-22 |
Glenmark Pharmaceuticals Limited |
Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
|
|
WO2009084020A2
(en)
|
2007-10-18 |
2009-07-09 |
Glenmark Pharmaceuticals Limited |
Topical composition comprising halobetasol and salicylic acid
|
|
CN105147608B
(zh)
|
2008-06-26 |
2019-12-10 |
安特里奥公司 |
真皮递送
|
|
MX2011003568A
(es)
*
|
2008-10-03 |
2011-06-09 |
Nexmed Holdings Inc |
Composicion estabilizada para el tratamiento de psoriasis.
|
|
US20100249060A1
(en)
*
|
2009-02-23 |
2010-09-30 |
Smith Jan G |
Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
|
|
DK2400951T3
(en)
|
2009-02-25 |
2018-12-03 |
Mayne Pharma Llc |
TOPICAL FOAM COMPOSITION
|
|
US20130310355A1
(en)
|
2009-12-15 |
2013-11-21 |
Young Pharmaceuticals, Inc. |
Low toxicity topical active agent delivery system
|
|
US9782341B2
(en)
|
2010-10-15 |
2017-10-10 |
John E. Kulesza |
Delivery of hydrophobic bioactive agents
|
|
US8809307B2
(en)
|
2010-11-22 |
2014-08-19 |
Dow Pharmaceutical Sciences, Inc. |
Pharmaceutical formulations containing corticosteroids for topical administration
|
|
US11957753B2
(en)
|
2010-11-22 |
2024-04-16 |
Bausch Health Ireland Limited |
Pharmaceutical formulations containing corticosteroids for topical administration
|
|
US8962028B2
(en)
|
2012-10-18 |
2015-02-24 |
MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company |
Topical steroid composition and method
|